RxDoctor Payments Data

Venessann Thornton-Mclendon

Family · Chicago, ILNPI 1437656527

Payments from drug & device makers

$3,630in general payments, 2019–2025

Across 199 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Neurocrine Biosciences, Inc.$861
  • Otsuka America Pharmaceutical, Inc.$479
  • Indivior Inc.$353
  • E.r. Squibb & Sons, L.L.C.$202
  • Lundbeck LLC$189
  • plus $494 from 4 others

What the payments were for

  • Food & beverage$3,55298%
  • Education$782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,630 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$78,263
Medicare patients
240
Services billed
676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate103$274,130
Abilify MaintenaAripiprazole16$43,461
OzempicSemaglutide45$42,520
EliquisApixaban16$17,623
FanaptIloperidone13$16,600
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen176$3,956
Fluphenazine Decanoate32$3,517
Olanzapine79$2,455
Albuterol Sulfate HfaAlbuterol Sulfate41$2,358
Bupropion XlBupropion Hcl32$1,637
Ventolin HfaAlbuterol Sulfate14$1,249
Clonidine11$1,215
Gabapentin68$1,187
Ziprasidone Hcl20$835
Benztropine Mesylate152$825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$1,052$274,130103 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$479$43,46116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →